Side Effects of Lacosamide
Lacosamide commonly causes dizziness, headache, somnolence, diplopia, nausea, and cardiovascular abnormalities, with most side effects being mild to moderate in severity. 1
Common Side Effects
Central Nervous System Effects:
- Dizziness is the most frequently reported side effect, occurring in significantly higher rates compared to placebo (RR 3.53) 2
- Abnormal coordination (RR 6.12) is a significant concern that can affect daily functioning 2
- Diplopia (double vision) is common (RR 5.29) and may impact quality of life 2
- Headache, though reported, is not statistically more common than with placebo 2
- Somnolence (drowsiness) may occur but is not significantly different from placebo in controlled studies 2
Gastrointestinal Effects:
Cardiovascular Effects:
Less Common but Serious Side Effects
Psychiatric Effects:
- Psychological symptoms have been reported, including rare cases of drug-induced psychosis 4
- No significant worsening of depression symptoms was observed in most patients; some patients with pre-existing depression (NDDI-E scores >15) showed improvement 5
- No significant effect on anxiety symptoms has been documented 5
Dermatological Effects:
- Skin rashes have been reported, though less frequently than with some other antiepileptic drugs 1
Hematological Effects:
- Hematotoxicity has been reported in post-marketing surveillance 1
Effects on Driving Performance
- Lacosamide may impair driving ability due to its effects on the central nervous system 3
- The Japanese Ministry of Health, Labour and Welfare guideline includes lacosamide among medications that require evaluation for their effects on driving performance 3
- Patients should be counseled about potential impairment of driving ability, particularly during initiation or dose changes 3
Dosing Considerations
- Higher doses of lacosamide (400 mg/day) are associated with increased incidence of adverse effects compared to lower doses (200 mg/day) 2
- Treatment withdrawal due to adverse effects is more common with lacosamide than with placebo (RR 1.88) 2
- Adverse effects are generally dose-dependent, with higher rates at 400-600 mg/day compared to 200 mg/day 2
Special Populations
- Limited data exists on lacosamide use in pregnancy, though the general principle in epilepsy management is that seizure control takes priority over theoretical medication risks 6
- Patients with cardiac conduction disorders require careful monitoring due to potential PR interval prolongation 1
Clinical Recommendations
- Start with lower doses and titrate slowly to minimize adverse effects 2
- Monitor for neurological side effects, particularly dizziness and coordination problems 1
- Patients should be advised about potential driving impairment, especially during treatment initiation 3
- Be vigilant for rare but serious psychiatric symptoms, particularly in patients with pre-existing mental health conditions 4
- Consider cardiac monitoring in patients with known cardiac conduction abnormalities 1